Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study
- 30 April 2011
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 95 (5), 1720-1724.e8
- https://doi.org/10.1016/j.fertnstert.2010.12.064
Abstract
No abstract availableKeywords
Funding Information
- EMD Serono
- Merck KGaA
This publication has 13 references indexed in Scilit:
- Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trialFertility and Sterility, 2009
- Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparisonFertility and Sterility, 2009
- A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertilityGynecological Endocrinology, 2007
- Clomiphene citrate—end of an era? a mini-reviewHuman Reproduction, 2005
- A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteersFertility and Sterility, 2004
- Characteristics of baseline ovarian cysts in clomiphene citrate ovulation cyclesFertility and Sterility, 2004
- Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertilityHuman Reproduction, 2003
- Aromatase inhibitors for the treatment of infertilityExpert Opinion on Investigational Drugs, 2003
- Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor respondersFertility and Sterility, 2002
- The Ovarian Androgen Producing Cells: A Review of Structure/Function Relationships1,2Endocrine Reviews, 1985